Federated Hermes
APGE

Federated Hermes’s Apogee Therapeutics APGE Stock Holding History

Federated Hermes’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27M Sell
17,081
-425,657
-96% -$38.3M ﹤0.01% 996
2026
Q1 		$37.3M Buy
442,738
+314,807
+246% +$22.9M 0.06% 327
2025
Q4 		$9.66M Buy
+127,931
New +$8.06M 0.02% 625

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Federated Hermes's APGE Position: Q2 2026 in Review

Federated Hermes reduced its Apogee Therapeutics (APGE) stake by 96% in Q2 2026, selling an estimated $38.3M and leaving 17,081 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #996.

Federated Hermes first reported a position in APGE in Q4 2025 and has held it in 3 quarters since. The position peaked at $37.3M in Q1 2026. 289 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Federated Hermes held 17,081 shares of Apogee Therapeutics worth $2.27M as of Q2 2026.
  • Federated Hermes sold 425,657 Apogee Therapeutics shares in Q2 2026, an estimated $38.3M.
  • Apogee Therapeutics made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #996 holding.
  • Federated Hermes first reported a position in Apogee Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Federated Hermes's Apogee Therapeutics position peaked at $37.3M in Q1 2026.
  • 289 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.